Skip to main content

Table 2 Age group, gender and topography of head and neck cancers in which the final diagnosis was revised after immunohistochemistry

From: Immunohistochemical analysis of undifferentiated and poorly-differentiated head and neck malignancies at a tertiary hospital in Nigeria

ORIGINAL HISTOLOGICAL DIAGNOSIS

FINAL DIAGNOSIS AFTER IMMUNOHISTOCHEMISTRY

AGE GROUP (years)

GENDER

TOPOGRAPHY

Carcinoma

Neuroendocrine carcinoma

25-44

Male

Lymph node

Carcinoma

Neuroendocrine carcinoma

45-64

Female

Nose

Carcinoma

Neuroendocrine carcinoma

45-64

Male

Nasopharynx

Carcinoma

Neuroendocrine carcinoma

25-44

Female

Nose

Carcinoma

Neuroendocrine carcinoma

15-24

Male

Palate

Carcinoma

Neuroendocrine carcinoma

≥65

Male

Nasopharynx

Carcinoma

Sarcoma

25-44

Male

Face/scalp

Carcinoma

Sarcoma

15-24

Male

Nasopharynx

Carcinoma

Sarcoma

45-64

Male

Lymph node

Carcinoma

Sarcoma

25-44

Male

Nasopharynx

Carcinoma

Sarcoma

25-44

Male

Nose

Carcinoma

Sarcoma

15-24

Male

Nose

Carcinoma

Sarcoma

45-64

Male

Nasopharynx

Carcinoma

Sarcoma

45-64

Female

Maxillofacial bone

Carcinoma

Lymphoma

≥65

Male

Nasopharynx

Carcinoma

Lymphoma

45-64

Male

Nasopharynx

Carcinoma

Lymphoma

25-44

Male

Oropharynx

Carcinoma

Lymphoma

----

Male

Oropharynx

Carcinoma

Lymphoma

15-24

Male

Maxillofacial bone

Carcinoma

Lymphoma

45-64

Male

Nose

Carcinoma

Lymphoma

25-44

Female

Nasopharynx

Carcinoma

Lymphoma

45-64

Female

Nasopharynx

Carcinoma

Carcinosarcoma

45-64

Male

Nasopharynx

Sarcoma

Carcinoma

45-64

Female

Face/scalp

Sarcoma

Lymphoma

15-24

Male

Maxillofacial bone

Sarcoma

Lymphoma

25-44

Male

Maxillofacial bone

Lymphoma

Sarcoma

25-44

Male

Nose

Neuroendocrine carcinoma

Sarcoma

45-64

Male

Nasopharynx